VolitionRx Statistics

Total Valuation

VolitionRx has a market cap or net worth of $58.88 million. The enterprise value is $52.65 million.

Market Cap	58.88M
Enterprise Value	52.65M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, after market close.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

VolitionRx has 82.93 million shares outstanding. The number of shares has increased by 36.19% in one year.

Shares Outstanding	82.93M
Shares Change (YoY)	+36.19%
Shares Change (QoQ)	+3.15%
Owned by Insiders (%)	23.17%
Owned by Institutions (%)	9.54%
Float	63.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	73.87
Forward PS	14.65
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	66.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.43

Current Ratio	0.43
Quick Ratio	0.38
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-140.02

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-150.20%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$7,246
Profits Per Employee	-$317,336
Employee Count	110
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.59% in the last 52 weeks. The beta is 1.14, so VolitionRx's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-53.59%
50-Day Moving Average	0.69
200-Day Moving Average	0.80
Relative Strength Index (RSI)	59.15
Average Volume (20 Days)	114,563

Short Selling Information

The latest short interest is 441,708, so 0.53% of the outstanding shares have been sold short.

Short Interest	441,708
Short Previous Month	513,989
Short % of Shares Out	0.53%
Short % of Float	0.70%
Short Ratio (days to cover)	4.50

Income Statement

In the last 12 months, VolitionRx had revenue of $797,029 and -$34.91 million in losses. Loss per share was -$0.46.

Revenue	797,029
Gross Profit	797,029
Operating Income	-35.33M
Pretax Income	-34.91M
Net Income	-34.91M
EBITDA	-33.26M
EBIT	-34.66M
Loss Per Share	-$0.46

Full Income Statement

Balance Sheet

The company has $11.77 million in cash and $5.55 million in debt, giving a net cash position of $6.22 million or $0.08 per share.

Cash & Cash Equivalents	11.77M
Total Debt	5.55M
Net Cash	6.22M
Net Cash Per Share	$0.08
Equity (Book Value)	-15.61M
Book Value Per Share	-0.19
Working Capital	-18.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.66 million and capital expenditures -$911,966, giving a free cash flow of -$18.57 million.

Operating Cash Flow	-17.66M
Capital Expenditures	-911,966
Free Cash Flow	-18.57M
FCF Per Share	-$0.23

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -4,432.36% and -4,379.63%.

Gross Margin	100.00%
Operating Margin	-4,432.36%
Pretax Margin	-4,379.63%
Profit Margin	-4,379.63%
EBITDA Margin	-4,172.82%
EBIT Margin	-4,348.57%
FCF Margin	-2,330.23%

Dividends & Yields

VolitionRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.19%
Shareholder Yield	-36.19%
Earnings Yield	-59.29%
FCF Yield	-31.54%

Analyst Forecast

The average price target for VolitionRx is $2.83, which is 298.59% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.83
Price Target Difference	298.59%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	157.44%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

VolitionRx has an Altman Z-Score of -21.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-21.17
Piotroski F-Score	2